Allergy Therapeutics
AGY.L
#6045
Rank
NZ$1.66 B
Marketcap
NZ$0.27
Share price
0.00%
Change (1 day)
72.99%
Change (1 year)

Earnings for Allergy Therapeutics (AGY.L)

Earnings in 2025: -NZ$89.97 Million

According to Allergy Therapeutics's latest financial reports the company's current earnings are NZ$75.57 Million. In 2025 the company made an earning of -NZ$89.97 Million a decrease over its 2024 earnings that were of -NZ$82.81 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Allergy Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025-NZ$89.97 Million8.65%
2024-NZ$82.81 Million-6.69%
2023-NZ$88.75 Million244.94%
2022-NZ$25.73 Million-404.35%
2021NZ$8.45 M-49.42%
2020NZ$16.71 M83.48%
2019NZ$9.1 M-159.83%
2018-NZ$15.23 Million255.48%
2017-NZ$4.29 Million-84.06%
2016-NZ$26.88 Million-1667.33%
2015NZ$1.71 M-44.68%
2014NZ$3.09 M130.59%
2013NZ$1.34 M-19.89%
2012NZ$1.67 M-127.05%
2011-NZ$6.21 Million2009.96%
2010-NZ$0.3 Million-99.07%
2009-NZ$31.51 Million-53.23%
2008-NZ$67.35 Million-21.86%
2007-NZ$86.2 Million356.94%
2006-NZ$18.87 Million230.75%
2005-NZ$5.71 Million-217.9%
2004NZ$4.83 M-58.79%
2003NZ$11.73 M-196.03%
2002-NZ$12.23 Million